ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
13 Diabetics Implanted With VeriMed RFID Microchip At Boston Diabetes EXPO
VeriChip
Corporation (Nasdaq: CHIP - News), a provider of RFID systems for
healthcare and patient-related needs, announced today it added 13 diabetic
patients to its VeriMed Patient Identification System network at a Boston
Diabetes EXPO sponsored by the American Diabetes Association (ADA).
At the Boston Diabetes EXPO, physicians implanted VeriMed RFID
microchips in conference attendees who signed up for the voluntary
procedure. The VeriMed Patient Identification System, which utilizes an
implantable RFID microchip in combination with a handheld RFID scanner and
a secure patient database, provides immediate access to important
identification and health information for patients who arrive at an
emergency department unable to communicate.
Scott R. Silverman, Chairman and CEO of VeriChip, commented, "We
continue to expand our presence at ADA events and focus on individuals with
diabetes as we believe they, and other high-risk populations, may benefit
greatly from the VeriMed Patient Identification System. Through the Atlanta
and Boston Diabetes EXPOs, we have now enrolled 31 more patients in our
system. Furthermore, these sign-ups by diabetic individuals underscore the
importance of our planned future development efforts to commercialize a
glucose-sensing implantable microchip, with our sister company Digital
Angel, which was awarded a patent on this breakthrough product."
The Diabetes EXPO is a patient-driven tradeshow, including professional
speakers and a variety of ADA program/event information, where exhibitors
from pharmaceutical and medical device companies display beneficial
products for diabetics. The Diabetes EXPO began in 1995 in Phoenix,
Arizona, and has grown to 18, metro, major and mid-size cities around the
U.S. The next event will be held in Chicago on April 28, 2007.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida, develops,
markets and sells radio frequency identification, or RFID, systems used to
identify, locate and protect people and assets. VeriChip's goal is to
become the leading provider of RFID systems for people in the healthcare
industry. VeriChip sells passive RFID systems for identification purposes
and active RFID systems for local-area location and identification
purposes. VeriChip recently began to market its VeriMed(TM) Patient
Identification System for rapidly and accurately identifying people who
arrive in an emergency room and are unable to communicate. This system uses
the first human-implantable passive RFID microchip, the implantable
VeriChip(TM), cleared for medical use in October 2004 by the United States
Food and Drug Administration.
VeriChip Corporation is majority-owned by Applied Digital Inc. (Nasdaq:
ADSX - News), which also owns a majority position in Digital Angel
Corporation (Amex: DOC - News).
Statements about the Company's future expectations, including future
revenues and earnings, and all other statements in this press release other
than historical facts are "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, Section 21E of the Securities
Exchange Act of 1934, and as that term is defined in the Private Litigation
Reform Act of 1995. Such forward-looking statements involve risks and
uncertainties and are subject to change at any time, and the Company's
actual results could differ materially from expected results. The Company
undertakes no obligation to update forward-looking statements to reflect
subsequently occurring events or circumstances. VeriChip Corporation
(Nasdaq: CHIP), a provider of RFID systems for healthcare and
patient-related needs, announced today it added 18 diabetic patients to its
VeriMed Patient Identification System at an Atlanta Diabetes EXPO sponsored
by the American Diabetes Association (ADA).
At the EXPO, physicians implanted VeriMed RFID microchips in conference
attendees who signed up for the voluntary procedure. The VeriMed Patient
Identification System, which utilizes an implantable RFID microchip in
combination with a handheld RFID scanner and a secure patient database,
provides immediate access to important health information for patients who
arrive at an emergency department unable to communicate.
Scott R. Silverman, Chairman and CEO of VeriChip, commented "We believe
the VeriMed Patient Identification System is an essential health care
solution for at-risk patients, including diabetics, who tend to present
with various co-morbidities and medications, and are more frequently
admitted to emergency departments. The ADA Diabetes EXPO provides us direct
access so we can continue to educate an important target audience."
The Expo is a patient-driven tradeshow, including professional speakers
and a variety of ADA program/event information, where exhibitors from
pharmaceutical and medical device companies display beneficial products for
diabetics. The Diabetes EXPO began in 1995 in Phoenix, Arizona, and has
grown to 18, metro, major and mid-size cities around the U.S. The next
event will be held in Boston on March 17.
VeriChip Corporation
http://www.verichipcorp.com
13 diabetici implanturi cu microcip RFID VeriMed diabet zaharat de la Boston EXPO - 13 Diabetics Implanted With VeriMed RFID Microchip At Boston Diabetes EXPO - articole medicale engleza - startsanatate